Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-1,494
Closed -$127K 396
2020
Q2
$127K Buy
+1,494
New +$103K 0.09% 191
2019
Q4
$549K Buy
5,785
+710
+14% +$65K 0.29% 174
2019
Q3
$444K Buy
+5,075
New +$424K 0.29% 134
2019
Q1
Sell
-4,130
Closed -$254K 445
2018
Q4
$254K Buy
4,130
+2,028
+96% +$147K 0.18% 162
2018
Q3
$176K Buy
2,102
+199
+10% +$18.2K 0.28% 249
2018
Q2
$174K Sell
1,903
-361
-16% -$33.7K 0.29% 168
2018
Q1
$192K Buy
2,264
+770
+52% +$69.9K 0.25% 74
2017
Q4
$127K Buy
+1,494
New +$142K 0.09% 191

Other funds holding APTV

Cerebellum's APTV Position: Q3 2020 in Review

Cerebellum sold out of Aptiv (APTV) in Q3 2020, closing a stake of 1,494 shares — an estimated $127K sold.

Cerebellum first reported a position in APTV in Q4 2017 and held it in 8 quarters. The position peaked at $549K in Q4 2019. 582 funds tracked by Wall St. Rank hold APTV as of Q3 2020.

  • Cerebellum reported no remaining Aptiv position as of Q3 2020 after selling out during the quarter.
  • Cerebellum sold 1,494 Aptiv shares in Q3 2020, an estimated $127K.
  • Cerebellum first reported a position in Aptiv in Q4 2017 and held it in 8 quarters.
  • Cerebellum's Aptiv position peaked at $549K in Q4 2019.
  • 582 funds tracked by Wall St. Rank held Aptiv as of Q3 2020.

Based on Cerebellum's 13F filing for Q3 2020, filed 21 Oct 2020.